Use of il-1 antagonists to treat gout and pseudogout

Details Use of il-1 antagonists to treat gout and pseudogout Use of il-1 antagonists to treat gout and pseudogout

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 38/20 (2006.01) A61P 19/02 (2006.01) A61P 19/06 (2006.01)

Patent

CA 2666629

Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout or pseudogout in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1 ) antagonist, wherein gout or pseudogout are inhibited or ameliorated. Preferably, the IL-1 antagonist is the protein of SEQ ID NO:10 (rilonacept).

L'invention concerne des procédés de traitement, d'inhibition ou de soulagement de la goutte, y compris la goutte aiguë chronique (réfractaire) ou la pseudo goutte chez un patient humain en ayant besoin. Lesdits procédés consistent à administrer à un sujet en ayant besoin une quantité thérapeutique d'un antagoniste d'interleukine 1 (IL-1 ) afin d'inhiber ou de soulager la goutte ou la pseudo goutte. De préférence, l'antagoniste IL-1 est la protéine SEQ ID NO:10 (rilonacept).

Affiliated with

Also associated with

Rating

Use of il-1 antagonists to treat gout and pseudogout does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of il-1 antagonists to treat gout and pseudogout, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-1 antagonists to treat gout and pseudogout will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1529757